Engimmune Therapeutics raises CHF15.5m in seed financing
Cancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2127 entries already.
Entries by Thomas Gabrielczyk
Switzerland shows sustained growth of biotech sector
The Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel.
Commission to establish EU health data space
Digital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space.
Increased Demand on HPAPIs Brings Renewed Focus on Product Development and Regulatory Requirements
The rapid growth of active pharmaceutical ingredients (APIs) has led to more biotech companies enlisting the support of strategic partners to navigate the regulatory environment and bring their innovative products to market.
Four new autoantigens trigger multiple sclerosis
Swiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice.
TWB partners with Processium and Syngulon
Industrial biotech project managment specialist Toulouse White Biotech (TWB) has joined forces with process developer Processium and industrial synbio start-up Syngulon.
Meat consumption must fall by at least 75 percent
If our planet is to continue feeding us in the future, rich countries must significantly reduce their meat consumption by at least 75% suggests a new study by German researchers.
Vigeneron updates gene therapy collab with Daiichi Sankyo
ViGeneron and Daiichi Sankyo have agreed a follow-on collaboration to evaluate vgAAVs as vectors for Daiichi Sankyo’ novel treatment of prevalent eye diseases.
Single-use market to reach $20.8bn by 2026
Analysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product.